Jessica Marksteiner
Vienna, 1090, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
The sodium/glucose cotransporter 2 inhibitor empagliflozin is a pharmacological chaperone of cardiac Nav1.5 channels.
Journal: American journal of physiology. Heart and circulatory physiology
Published: August 12, 2025
Inhibition of tenascin C rescues abnormally reduced Na currents in dystrophin-deficient ventricular cardiomyocytes.
Journal: American journal of physiology. Heart and circulatory physiology
Published: August 11, 2025
Targeting Skeletal Muscle in Duchenne Muscular Dystrophy: Integrating in Silico and Experimental Approaches to Sodium-Glucose Cotransporter-2 Inhibition.
Journal: The American journal of pathology
Published: April 20, 2025
Chronic administration of ivabradine improves cardiac Ca handling and function in a rat model of Duchenne muscular dystrophy.
Journal: Scientific reports
Published: September 16, 2024
Cell size induced bias of current density in hypertrophic cardiomyocytes.
Journal: Channels (Austin, Tex.)
Published: June 05, 2024
Empagliflozin treatment rescues abnormally reduced Na+ currents in ventricular cardiomyocytes from dystrophin-deficient mdx mice.
Journal: American journal of physiology. Heart and circulatory physiology
Published: December 15, 2023
Ivabradine acutely improves cardiac Ca handling and function in a rat model of Duchenne muscular dystrophy.
Journal: Physiological reports
Published: January 23, 2023
Modulation of cardiac ventricular conduction: Impact on QRS duration, amplitude and dispersion.
Journal: European journal of pharmacology
Published: August 02, 2022
Microdystrophin Therapy Rescues Impaired Na Currents in Cardiac Purkinje Fibers From Dystrophin-Deficient Mdx Mice.
Journal: Circulation. Arrhythmia and electrophysiology
Published: August 02, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026